CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+17.85%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$709M
AUM Growth
+$144M
(+25%)
Cap. Flow
+$90.2M
Cap. Flow
% of AUM
12.73%
Top 10 Holdings %
Top 10 Hldgs %
61.15%
Holding
35
New
4
Increased
10
Reduced
4
Closed
2
Top Buys
| 1 |
Dianthus Therapeutics
DNTH
|
+$27.5M |
| 2 |
FMI
Foundation Medicine, Inc.
FMI
|
+$22.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$18.2M |
| 4 |
BioLife Solutions
BLFS
|
+$11.4M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$10.9M |
Top Sells
| 1 |
Evolent Health
EVH
|
+$11.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$10.1M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$5.42M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.87M |
| 5 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$1.99M |
Sector Composition
| 1 | Healthcare | 91.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neogen
NEOG
$1.25B
| $5.21M | 0.73% |
130,000
| – | – |
|
27
CytomX Therapeutics
CTMX
$346M
| $4.74M | 0.66% |
207,500
| – | – |
|
|
NTGN
28
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $4.26M | 0.6% |
+338,345
| New | +$4.26M |
|
29
Zai Lab
ZLAB
$3.47B
| $3.14M | 0.44% |
135,000
| – | – |
|
|
JNCE
30
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.87M | 0.4% |
375,000
-260,000
| -41% | -$1.99M |
|
31
CareDx
CDNA
$714M
| $2.45M | 0.34% |
+200,000
| New | +$2.45M |
|
32
Q32 Bio
QTTB
$20.6M
| $2.35M | 0.33% |
6,389
+3,056
| +92% | +$1.12M |
|
33
Adverum Biotechnologies
ADVM
$72.2M
| – | – |
-30,000
| Closed | -$1.74M |
|
|
34
iShares Biotechnology ETF
IBB
$5.68B
| – | – |
-95,000
| Closed | -$10.1M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| – | – |
0
| – | – |
|